Article Information
History
- October 20, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- 1Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
- 2Departments of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
- 3Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
- 4Department of Investigational Cancer Therapeutics, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
- 5Quantitative Sciences Program, The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, TX 77030, USA
- ↵*To whom correspondence should be addressed. mjha{at}mdanderson.org
Posted October 20, 2021.
CombPDX: a unified statistical framework for evaluating drug synergism in patient-derived xenografts
